AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
MastectomyBreast NeoplasmsMastectomy, SimpleMastectomy, Modified RadicalBreastMastectomy, SegmentalMastectomy, RadicalCarcinoma, Ductal, BreastMastectomy, SubcutaneousReceptors, EstrogenMammaplastyTamoxifenPrognosisReceptor, erbB-2Neoplasm StagingReceptors, ProgesteroneTumor Markers, BiologicalChemotherapy, AdjuvantLymphatic MetastasisAxillaNeoplasm MetastasisAntineoplastic Agents, HormonalCell Line, TumorCarcinoma, LobularBreast Neoplasms, MaleNeoplasm Recurrence, LocalCarcinoma, Intraductal, NoninfiltratingDisease-Free SurvivalBreast DiseasesNipplesGene Expression Regulation, NeoplasticMammographyNeoplasm InvasivenessAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisAntineoplastic AgentsGenes, BRCA1Follow-Up StudiesTreatment OutcomeRetrospective StudiesNeoplasmsSurvival RateRisk FactorsRadiotherapy, AdjuvantPostmenopauseCombined Modality TherapyEpirubicinCarcinomaImmunohistochemistryNeoplasm ProteinsCyclophosphamideGenes, BRCA2Case-Control StudiesProspective StudiesPremenopauseLymph NodesFluorouracilLymph Node ExcisionAromatase InhibitorsSentinel Lymph Node BiopsyBreast ImplantsBRCA2 ProteinMenopauseNeoplastic Cells, CirculatingMultivariate AnalysisGenetic Predisposition to DiseaseDrug Resistance, NeoplasmOvarian NeoplasmsLung NeoplasmsTime FactorsNeoplasms, Hormone-DependentBRCA1 ProteinEarly Detection of CancerNeoadjuvant TherapyAge FactorsGene Expression ProfilingCohort StudiesGenes, erbB-2Bone NeoplasmsCarcinoma, DuctalEstrogen Receptor alphaKaplan-Meier EstimatePredictive Value of TestsRiskRisk AssessmentReverse Transcriptase Polymerase Chain ReactionAnthracyclinesEstrogen AntagonistsMCF-7 CellsSensitivity and SpecificityDisease ProgressionEstrogensTumor Cells, CulturedNeoplasm GradingMice, NudeCarcinoma in SituIncidenceSurvivorsDNA, NeoplasmAntibodies, Monoclonal, Humanized